2010•China Medical HeraldRequires access

Clinical observation of Lamivudine for chronic hepatitis B cirrhosis in 94 cases

Xiaobin Zhou

Open publisher page 0 citations

Abstract

Objective:To evaluate the therapeutic effect of Lamivudine in the treatment of chronic hepatitis B cirrhosis patients.Methods:94 patients with chronic hepatitis B cirrhosis were selected and divided into treatment group and con trol group randomly,both groups were treated with conventional therapy,the treatment group took 100 mg Lamivudine once per day.12 months was named as a course.Results:For treatment group,liver function's outcomes of total bilirubin and ALT liver fibrosis HA,PCⅢ,CⅣ were much improved which showed that Lamivudine can help improve liver function and liver fibrosis.After 12 months' treatment,the quantitative HBV DNA of 27 patients with Lamivudine therapy were de creased.The negative rate in treatment group was 51.06% and in control group was 6.38%.HBeAg negative rate of the treatment group were significantly higher than that of the control group and showed a significant effect on Lamivudine in the treatment of chronic hepatitis B cirrhosis.Conclusion:Lamivudine has good effects on inhibiting fibrosis,improving liver function and prognosis,and less adverse reaction.So Lamivudine is quite a good drug on treating chronic hepatitis B cirrhosis.

About this research paper

What this paper is about

Objective:To evaluate the therapeutic effect of Lamivudine in the treatment of chronic hepatitis B cirrhosis patients.Methods:94 patients with chronic hepatitis B cirrhosis were selected and divided into treatment group and con trol group randomly,both groups were treated with conventional therapy,the treatment group took 100 mg Lamivudine once per day.12 months was named as a course.Results:For treatment group,liver function's outcomes of total bilirubin and ALT liver fibrosis HA,PCⅢ,CⅣ were much improved which showed that Lamivudine can help improve liver function and liver fibrosis.After 12 months' treatment,the quantitative HBV DNA of 27 patients with Lamivudine therapy were de creased.The negative rate in treatment group was 51.06% and in control group was 6.38%.HBeAg negative rate of the treatment group were significantly higher than that of the control group and showed a significant effect on Lamivudine in the treatment of chronic hepatitis B cirrhosis.Conclusion:Lamivudine has good effects on inhibiting fibrosis,improving liver function and prognosis,and less adverse reaction.So Lamivudine is quite a good drug on treating chronic hepatitis B cirrhosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the therapeutic effect of Lamivudine in the treatment of chronic hepatitis B cirrhosis patients.Methods:94 patients with chronic hepatitis B cirrhosis were selected and divided into treatment group and con trol group randomly,both groups were treated with conventional therapy,the treatment group took 100 mg Lamivudine once per day.12 months was named as a course.Results:For treatment group,liver function's outcomes of total bilirubin and ALT liver fibrosis HA,PCⅢ,CⅣ were much improved which showed that Lamivudine can help improve liver function and liver fibrosis.After 12 months' treatment,the quantitative HBV DNA of 27 patients with Lamivudine therapy were de creased.The negative rate in treatment group was 51.06% and in control group was 6.38%.HBeAg negative rate of the treatment group were significantly higher than that of the control group and showed a significant effect on Lamivudine in the treatment of chronic hepatitis B cirrhosis.Conclusion:Lamivudine has good effects on inhibiting fibrosis,improving liver function and prognosis,and less adverse reaction.So Lamivudine is quite a good drug on treating chronic hepatitis B cirrhosis.

Key concepts: Lamivudine, Medicine, Cirrhosis, Gastroenterology, Internal medicine, HBeAg, Liver function, Chronic hepatitis

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation of Lamivudine for chronic hepatitis B cirrhosis in 94 cases — Research Paper | ScholarLens